Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for SARS
Perform Another (Advanced) Search
11 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Study Posting (4801) Trial #160109, Osteoporosis, Arcadia, CA ...Trial Information A Double-Bind Study to Investigate the Effect of a Single Injection of SAR 164877 (REGN475) on the Reduction of Pain from Vertebral Fracture Due to Osteoporosis. Sanofi-aventis is conducting a research study to find out if an investigational drug called SAR 164877 (REGN475) will reduce pain from a vertebral fracture due to osteoporosis. Your participation will ...View Page
2. Study Posting (4801) Trial #160108, Spinal Cord Injuries, Arcadia, CA ...Trial Information A Double-Bind Study to Investigate the Effect of a Single Injection of SAR 164877 (REGN475) on the Reduction of Pain from Vertebral Fracture Due to Osteoporosis. Sanofi-aventis is conducting a research study to find out if an investigational drug called SAR 164877 (REGN475) will reduce pain from a vertebral fracture due to osteoporosis. Your participation will ...View Page
3. CenterWatch: New Medical Therapies in Disease Category (5), Acute Rhinitis ...phase II trial of CDX-313 nasal spray for the treatment of seasonal allergic rhinitis (SAR). This randomized, double-blind, three-way cross-over study enrolled 108 subjects with SAR. The subjects received CDX-313 nasal spray (Budesonide + Azelastine), Rhinocort Aqua + Astelin Nasal Spray or ...View Page
4. CenterWatch: New Medical Therapies in Disease Category (715), Allergies & Asthma ...phase II trial of CDX-313 nasal spray for the treatment of seasonal allergic rhinitis (SAR). This randomized, double-blind, three-way cross-over study enrolled 108 subjects with SAR. The subjects received CDX-313 nasal spray (Budesonide + Azelastine), Rhinocort Aqua + Astelin Nasal Spray or ...View Page
5. Study Posting (367) Trial #59677, Allergy (Pediatric), Louisville, KY ...Eligibility Criteria: • Ages 2 - 5. • Must have 1-year history of PAR with or without SAR, positive skin prick test to relevant perennial allergen. • No URI or sinus infection within 2 ...View Page
6. CenterWatch: Clinical Trials in Category (793) Spinal Cord Injuries ...Research Institute A Double-Bind Study to Investigate the Effect of a Single Injection of SAR 164877 (REGN475) on the Reduction of Pain from Vertebral Fracture Due to Osteoporosis. Massachusetts Boston ...View Page
7. Newly Approved Drug Therapies (747) Clarinex, Schering-Plough, ...Clarinex, in an oral tablet formulation, was approved for the treatment of seasonal allergic rhinitis (SAR)in adults and children over 12 years of age in December 2001. In February 2002 ......most common allergic disorder in the United States, affecting up to 30% of the population.SAR is considered a response to outdoor allergens, while PAR pertains to indoor allergens. AR symptoms ...View Page
8. CenterWatch: Clinical Trials in Category (111) Osteoporosis ...Research Institute A Double-Bind Study to Investigate the Effect of a Single Injection of SAR 164877 (REGN475) on the Reduction of Pain from Vertebral Fracture Due to Osteoporosis. Walnut Creek ...View Page
9. CenterWatch: New Medical Therapies in Disease Category (804), Rhinitis, Allergic, Perennial ...a phase III trial of epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR). This fourteen-day, randomized, double-blind trial enrolled seven hundred and ninety eight subjects with documented SAR during mountain cedar season in south central Texas. The subjects received epinastine (0.10% and ...View Page
10. CenterWatch: New Medical Therapies in Disease Category (166), Allergy ...a phase III trial of epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR). This fourteen-day, randomized, double-blind trial enrolled seven hundred and ninety eight subjects with documented SAR during mountain cedar season in south central Texas. The subjects received epinastine (0.10% and ...View Page
11. CenterWatch Clinical Research Profile (4801) Trial #1967, Advanced Pain Research Institute, Arcadia, CA ...recruiting patients: • A Double-Bind Study to Investigate the Effect of a Single Injection of SAR 164877 (REGN475) on the Reduction of Pain from Vertebral Fracture Due to Osteoporosis. • A Double ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.